| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Revenue | $18.4M | +153.2% |
| Cost of Revenue | $13.9M | +149.9% |
| Gross Profit | $4.5M | +164.1% |
| R&D Expense | $238K | +56.6% |
| SG&A Expense | $3.6M | +119.3% |
| Operating Income | -$1.8M | -12.9% |
| Pre-tax Income | -$1.3M | -108.5% |
| Net Income | -$1.3M | -108.5% |
| EPS (Basic) | -$0.13 |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.3M | +84.4% |
| Short-term Investments | $4.4M | — |
| Accounts Receivable | $1.8M | +288.1% |
| Inventory | $4.0M | +162.9% |
| Current Assets | $13.4M | +299.7% |
| Total Assets | $14.9M | +159.7% |
| Current Liabilities | $5.4M | -9.8% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.4M | -99.6% |
| Capital Expenditures | $20K | +900.0% |
| Investing Cash Flow | -$5.0M | -1004.4% |
| Financing Cash Flow | $9.4M | +592.1% |
| Free Cash Flow | -$3.4M | -100.5% |
| -18.2% |
| EPS (Diluted) | -$0.13 | -18.2% |
| Long-term Debt |
| $1.9M |
| +0.0% |
| Total Liabilities | $5.4M | -29.7% |
| Stockholders' Equity | $9.4M | +568.2% |